On February 22, 2023 Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, reported that Joseph Tucker, Ph.D., Chief Executive Officer, will present at the Gravitas Securities Inc. 6th Annual Growth Conference being held Thursday, March 2, 2023, at the Fairmont Pacific Rim Hotel in Vancouver, British Columbia (Press release, Enveric Biosciences, FEB 22, 2023, View Source [SID1234627510]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the presentations are as follows:

Presentation Format:

Healthcare Panel

Date:

Thursday, March 2, 2023

Time:

1:40 p.m. PST

Location:

Fairmont Pacific Rim Hotel

Presentation Format:

Company Presentation

Date:

Thursday, March 2, 2023

Time:

2:00 p.m. PST

Location:

Sapphire Ballroom, Fairmont Pacific Rim Hotel

During the conference, Dr. Tucker will host individual one-on-one meetings with registered investors, showcasing Enveric’s business and clinical development strategy, recent corporate achievements, and anticipated milestones.